Experienced in Tetanus

Fadima C. Haidara

Bamako, BKO, ML 
Experienced in Tetanus
Bamako, BKO, ML 
OverviewLocationsClinical Research

Overview

Fadima Haidara practices in Bamako, Mali. Ms. Haidara is rated as an Experienced expert by MediFind in the treatment of Tetanus. Her top areas of expertise are Bacterial Meningitis, Meningitis, Diarrhea, and Flu.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Tetanus.

Gender
Female

Locations

Bamako, BKO, Mali
Other Locations
Mali

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Biological
Study Phase: Phase 2
Phase 3, Observer-blind, Randomized, Active Controlled Trial to Assess the Safety of an Investigational Meningococcal Serogroups ACYWX Conjugate Vaccine (NmCV-5) and Compare Its Immunogenicity to a Licensed Meningococcal Serogroups ACYW Conjugate Vaccine (Menactra®), in Healthy Subjects 2 to 29 Years of Age
Phase 3, Observer-blind, Randomized, Active Controlled Trial to Assess the Safety of an Investigational Meningococcal Serogroups ACYWX Conjugate Vaccine (NmCV-5) and Compare Its Immunogenicity to a Licensed Meningococcal Serogroups ACYW Conjugate Vaccine (Menactra®), in Healthy Subjects 2 to 29 Years of Age
Enrollment Status: Completed
Publish Date: July 27, 2021
Intervention Type: Biological
Study Drugs: NmCV-5, Menactra
Study Phase: Phase 3
View 1 Less Clinical Trial

47 Total Publications

Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.
Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.
Journal: The New England journal of medicine
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Haidara's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile